Vaccine Safety International Monitoring
Vaccine safety is an important aspect of mass immunization of the population. Adverse reactions that occur following vaccination result in a decrease in public confidence. The aim of this research was to identify information on the development of adverse events after immunization with vaccines inclu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-03-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839581777008525312 |
|---|---|
| author | M. A. Darmostukova I. I. Snegireva N. Yu. Velts A. S. Kazakov R. N. Alyautdin |
| author_facet | M. A. Darmostukova I. I. Snegireva N. Yu. Velts A. S. Kazakov R. N. Alyautdin |
| author_sort | M. A. Darmostukova |
| collection | DOAJ |
| description | Vaccine safety is an important aspect of mass immunization of the population. Adverse reactions that occur following vaccination result in a decrease in public confidence. The aim of this research was to identify information on the development of adverse events after immunization with vaccines included into the national vaccination calendars of the USA, European Union (EU), Japan, China, South Korea and India. Particular attention was paid to vaccines that are not included in the vaccination calendar, but are presented in the Russian Federation. During monitoring of vaccination against human papillomavirus information in the European Union, Japan and the United States, according the possible connection with development of autoimmune diseases was refuted. Monitoring of adverse events after vaccination with rotavirus vaccine I generation in the USA, EU and India, allowed to establish a link with the development of intestine invagination and limit the use of this medicinal product in favor of vaccine II generation. After starting vaccination against influenza was detected narcolepsy as a complication of this procedure; and when analyzing the complications of meningococcal vaccination Guillain — Barre syndrome was detected. We also analyzed information on various complications associated with vaccination against Japanese viral encephalitis, which was included into the national vaccination calendar of countries in Asia and the Pacifi c region — China, India, Japan, and South Korea. The main complications registered in the PRC after the introduction of Japanese encephalitis vaccine into the national vaccination calendar included: febrile seizures, thrombocytopenic purpura, encephalitis and meningitis. The main safety concerns about vaccines included into the national vaccination calendars of EU countries, the USA and the Asia-Pacific region concern vaccines that have recently appeared on the pharmaceutical market. |
| format | Article |
| id | doaj-art-98a79837b36a4ffb94d17c74b19aa6c3 |
| institution | Matheson Library |
| issn | 2312-7821 2619-1164 |
| language | Russian |
| publishDate | 2019-03-01 |
| publisher | Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| record_format | Article |
| series | Безопасность и риск фармакотерапии |
| spelling | doaj-art-98a79837b36a4ffb94d17c74b19aa6c32025-08-04T10:16:31ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642019-03-017161410.30895/2312-7821-2019-7-1-6-14126Vaccine Safety International MonitoringM. A. Darmostukova0I. I. Snegireva1N. Yu. Velts2A. S. Kazakov3R. N. Alyautdin4Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal Products; Peoples' Friendship University of RussiaScientific Centre for Expert Evaluation of Medicinal ProductsVaccine safety is an important aspect of mass immunization of the population. Adverse reactions that occur following vaccination result in a decrease in public confidence. The aim of this research was to identify information on the development of adverse events after immunization with vaccines included into the national vaccination calendars of the USA, European Union (EU), Japan, China, South Korea and India. Particular attention was paid to vaccines that are not included in the vaccination calendar, but are presented in the Russian Federation. During monitoring of vaccination against human papillomavirus information in the European Union, Japan and the United States, according the possible connection with development of autoimmune diseases was refuted. Monitoring of adverse events after vaccination with rotavirus vaccine I generation in the USA, EU and India, allowed to establish a link with the development of intestine invagination and limit the use of this medicinal product in favor of vaccine II generation. After starting vaccination against influenza was detected narcolepsy as a complication of this procedure; and when analyzing the complications of meningococcal vaccination Guillain — Barre syndrome was detected. We also analyzed information on various complications associated with vaccination against Japanese viral encephalitis, which was included into the national vaccination calendar of countries in Asia and the Pacifi c region — China, India, Japan, and South Korea. The main complications registered in the PRC after the introduction of Japanese encephalitis vaccine into the national vaccination calendar included: febrile seizures, thrombocytopenic purpura, encephalitis and meningitis. The main safety concerns about vaccines included into the national vaccination calendars of EU countries, the USA and the Asia-Pacific region concern vaccines that have recently appeared on the pharmaceutical market.https://www.risksafety.ru/jour/article/view/135vaccinesvaccine pharmacovigilanceadverse events following immunizationaefivaersrotavirus vaccinenarcolepsyhuman papillomavirus vaccinejapanese encephalitis virus vaccine |
| spellingShingle | M. A. Darmostukova I. I. Snegireva N. Yu. Velts A. S. Kazakov R. N. Alyautdin Vaccine Safety International Monitoring Безопасность и риск фармакотерапии vaccines vaccine pharmacovigilance adverse events following immunization aefi vaers rotavirus vaccine narcolepsy human papillomavirus vaccine japanese encephalitis virus vaccine |
| title | Vaccine Safety International Monitoring |
| title_full | Vaccine Safety International Monitoring |
| title_fullStr | Vaccine Safety International Monitoring |
| title_full_unstemmed | Vaccine Safety International Monitoring |
| title_short | Vaccine Safety International Monitoring |
| title_sort | vaccine safety international monitoring |
| topic | vaccines vaccine pharmacovigilance adverse events following immunization aefi vaers rotavirus vaccine narcolepsy human papillomavirus vaccine japanese encephalitis virus vaccine |
| url | https://www.risksafety.ru/jour/article/view/135 |
| work_keys_str_mv | AT madarmostukova vaccinesafetyinternationalmonitoring AT iisnegireva vaccinesafetyinternationalmonitoring AT nyuvelts vaccinesafetyinternationalmonitoring AT askazakov vaccinesafetyinternationalmonitoring AT rnalyautdin vaccinesafetyinternationalmonitoring |